Cargando…
Immunogenicity, Impact on Carriage and Reactogenicity of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine in Kenyan Children Aged 1–4 Years: A Randomized Controlled Trial
BACKGROUND: The impact on carriage and optimal schedule for primary vaccination of older children with 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) are unknown. METHODS: 600 Kenyan children aged 12–59 months were vaccinated at days 0, 60 and 180 in...
Autores principales: | Hammitt, Laura L., Ojal, John, Bashraheil, Mahfudh, Morpeth, Susan C., Karani, Angela, Habib, Ahsan, Borys, Dorota, Goldblatt, David, Scott, J. Anthony G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897448/ https://www.ncbi.nlm.nih.gov/pubmed/24465570 http://dx.doi.org/10.1371/journal.pone.0085459 |
Ejemplares similares
-
Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers
por: Feazel, Leah M., et al.
Publicado: (2015) -
Population effect of 10-valent pneumococcal conjugate vaccine on
nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable
Haemophilus influenzae in Kilifi, Kenya: findings from
cross-sectional carriage studies
por: Hammitt, Laura L, et al.
Publicado: (2014) -
10‐valent pneumococcal non‐typeable Haemophilus influenzae protein‐D conjugate vaccine (PHiD‐CV) induces memory B cell responses in healthy Kenyan toddlers
por: Muema, D. M., et al.
Publicado: (2015) -
Safety and reactogenicity of primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Vietnamese infants: a randomised, controlled trial
por: Huu, Tran Ngoc, et al.
Publicado: (2013) -
Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trial
por: Horn, Michael, et al.
Publicado: (2020)